Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 454 entries
Sorted by: Best Match Show Resources per page
YOUTH: decisions and challenges in designing an osteoporosis prevention intervention for teen girls

Non-school settings

Ritenbaugh C, Stevens VJ.
GSID: o9UGNLFnW_MJ
LL DeBar, C Ritenbaugh, N Vuckovic, VJ Stevens… - Preventive …, 2004 - Elsevier

… We conducted the study because little research targets youth in non-school settings, such as medical plans. As the majority of children and adolescents (approximately 80%) visit a medical provider at least annually (representing 76 million annual contacts with...

Cite
DeBar, L. L., Ritenbaugh, C., Vuckovic, N., Stevens, V. J., Aickin, M., Elliot, D., ... & Irving, L. M. (2004). YOUTH: decisions and challenges in designing an osteoporosis prevention intervention for teen girls. Preventive Medicine, 39(5), 1047-1055.
DeBar, Lynn L., et al. "YOUTH: decisions and challenges in designing an osteoporosis prevention intervention for teen girls." Preventive Medicine 39.5 (2004): 1047-1055.
Copy Download .nbib Format: MLA
Real-world simultaneous alcohol and cannabis use: An ecological study of situational motives and social and physical contexts

Latinx/Hispanic ethnicity

Jackson KM, Stevens AK, Sokolovsky AW.
GSID: NM_PfX7Ec40J
KM Jackson, AK Stevens, AW Sokolovsky… - Psychology of …, 2021 - psycnet.apa.org

… 1.3); 12.2% were Latinx/Hispanic and 30.7% were non-White (3.4% Black, 12.7% Asian, 0.4% Native American, 0.6% Asian Pacific, 3.9% other, and 9.8% more than one race). Students …

Cite
Jackson, K. M., Stevens, A. K., Sokolovsky, A. W., Hayes, K. L., & White, H. R. (2021). Real-world simultaneous alcohol and cannabis use: An ecological study of situational motives and social and physical contexts. Psychology of Addictive Behaviors, 35(6), 698.
Jackson, Kristina M., et al. "Real-world simultaneous alcohol and cannabis use: An ecological study of situational motives and social and physical contexts." Psychology of Addictive Behaviors 35.6 (2021): 698.
Copy Download .nbib Format: MLA
Draft Genome Sequence of .

Genome announcements

Adaikpoh BI, Dowd SE, Stevens DC.
PMID: 28232451
Genome Announc. 2017 Feb 23;5(8). doi: 10.1128/genomeA.01678-16.

In an effort to explore myxobacterial natural product biosynthetic pathways, the draft genome sequence of

Cite
Adaikpoh BI, Dowd SE, Stevens DC. Draft Genome Sequence of . Genome Announc. 2017;5(8)doi: 10.1128/genomeA.01678-16.
Adaikpoh, B. I., Dowd, S. E., & Stevens, D. C. (2017). Draft Genome Sequence of . Genome announcements, 5(8), . https://doi.org/10.1128/genomeA.01678-16
Adaikpoh, Barbara I, et al. "Draft Genome Sequence of ." Genome announcements vol. 5,8 (2017). doi: https://doi.org/10.1128/genomeA.01678-16
Adaikpoh BI, Dowd SE, Stevens DC. Draft Genome Sequence of . Genome Announc. 2017 Feb 23;5(8). doi: 10.1128/genomeA.01678-16. PMID: 28232451; PMCID: PMC5323630.
Copy Download .nbib Format: NLM
Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.

Nature genetics

Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, Chatterjee N, Thorleifsson G, Sulem P, Liu G, Kaaks R, Henrion M, Kinnersley B, Vallée M, Le Calvez-Kelm F, Stevens VL, Gapstur SM, Chen WV, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Gabrielsen ME, Skorpen F, Vatten L, Njølstad I, Chen C, Goodman G, Benhamou S, Vooder T, Välk K, Nelis M, Metspalu A, Lener M, Lubiński J, Johansson M, Vineis P, Agudo A, Clavel-Chapelon F, Bueno-de-Mesquita HB, Trichopoulos D, Khaw KT, Johansson M, Weiderpass E, Tjønneland A, Riboli E, Lathrop M, Scelo G, Albanes D, Caporaso NE, Ye Y, Gu J, Wu X, Spitz MR, Dienemann H, Rosenberger A, Su L, Matakidou A, Eisen T, Stefansson K, Risch A, Chanock SJ, Christiani DC, Hung RJ, Brennan P, Landi MT, Houlston RS, Amos CI.
PMID: 28358128
Nat Genet. 2017 Mar 30;49(4):651. doi: 10.1038/ng0417-651a.

No abstract available.

Cite
Wang Y, McKay JD, Rafnar T, et al. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2017;49(4):651doi: 10.1038/ng0417-651a.
Wang, Y., McKay, J. D., Rafnar, T., Wang, Z., Timofeeva, M. N., Broderick, P., Zong, X., Laplana, M., Wei, Y., Han, Y., Lloyd, A., Delahaye-Sourdeix, M., Chubb, D., Gaborieau, V., Wheeler, W., Chatterjee, N., Thorleifsson, G., Sulem, P., Liu, G., Kaaks, R., Henrion, M., Kinnersley, B., Vallée, M., Le Calvez-Kelm, F., Stevens, V. L., Gapstur, S. M., Chen, W. V., Zaridze, D., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., Fabianova, E., Mates, D., Bencko, V., Foretova, L., Janout, V., Krokan, H. E., Gabrielsen, M. E., Skorpen, F., Vatten, L., Njølstad, I., Chen, C., Goodman, G., Benhamou, S., Vooder, T., Välk, K., Nelis, M., Metspalu, A., Lener, M., Lubiński, J., Johansson, M., Vineis, P., Agudo, A., Clavel-Chapelon, F., Bueno-de-Mesquita, H. B., Trichopoulos, D., Khaw, K. T., Johansson, M., Weiderpass, E., Tjønneland, A., Riboli, E., Lathrop, M., Scelo, G., Albanes, D., Caporaso, N. E., Ye, Y., Gu, J., Wu, X., Spitz, M. R., Dienemann, H., Rosenberger, A., Su, L., Matakidou, A., Eisen, T., Stefansson, K., Risch, A., Chanock, S. J., Christiani, D. C., Hung, R. J., Brennan, P., Landi, M. T., Houlston, R. S., & Amos, C. I. (2017). Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nature genetics, 49(4), 651. https://doi.org/10.1038/ng0417-651a
Wang, Yufei, et al. "Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer." Nature genetics vol. 49,4 (2017): 651. doi: https://doi.org/10.1038/ng0417-651a
Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, Chatterjee N, Thorleifsson G, Sulem P, Liu G, Kaaks R, Henrion M, Kinnersley B, Vallée M, Le Calvez-Kelm F, Stevens VL, Gapstur SM, Chen WV, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Gabrielsen ME, Skorpen F, Vatten L, Njølstad I, Chen C, Goodman G, Benhamou S, Vooder T, Välk K, Nelis M, Metspalu A, Lener M, Lubiński J, Johansson M, Vineis P, Agudo A, Clavel-Chapelon F, Bueno-de-Mesquita HB, Trichopoulos D, Khaw KT, Johansson M, Weiderpass E, Tjønneland A, Riboli E, Lathrop M, Scelo G, Albanes D, Caporaso NE, Ye Y, Gu J, Wu X, Spitz MR, Dienemann H, Rosenberger A, Su L, Matakidou A, Eisen T, Stefansson K, Risch A, Chanock SJ, Christiani DC, Hung RJ, Brennan P, Landi MT, Houlston RS, Amos CI. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2017 Mar 30;49(4):651. doi: 10.1038/ng0417-651a. PMID: 28358128.
Copy Download .nbib Format: NLM
Capturing incentives and avoiding penalties: The carrot and the stick.

Neurology. Clinical practice

Stevens JC.
PMID: 29473632
Neurol Clin Pract. 2013 Aug;3(4):341-347. doi: 10.1212/CPJ.0b013e3182a1b8bd.

Over the past decade, health care in the United States has been a topic of intense political debate, resulting in dramatic legislative, regulatory, and economic changes. These changes have occurred due to the unsustainable rise of health care costs...

Cite
Stevens JC. Capturing incentives and avoiding penalties: The carrot and the stick. Neurol Clin Pract. 2013;3(4):341-347doi: 10.1212/CPJ.0b013e3182a1b8bd.
Stevens, J. C. (2013). Capturing incentives and avoiding penalties: The carrot and the stick. Neurology. Clinical practice, 3(4), 341-347. https://doi.org/10.1212/CPJ.0b013e3182a1b8bd
Stevens, James C. "Capturing incentives and avoiding penalties: The carrot and the stick." Neurology. Clinical practice vol. 3,4 (2013): 341-347. doi: https://doi.org/10.1212/CPJ.0b013e3182a1b8bd
Stevens JC. Capturing incentives and avoiding penalties: The carrot and the stick. Neurol Clin Pract. 2013 Aug;3(4):341-347. doi: 10.1212/CPJ.0b013e3182a1b8bd. PMID: 29473632; PMCID: PMC5765961.
Copy Download .nbib Format: NLM
Conformal Robotic Stereolithography.

3D printing and additive manufacturing

Stevens AG, Oliver CR, Kirchmeyer M, Wu J, Chin L, Polsen ES, Archer C, Boyle C, Garber J, Hart AJ.
PMID: 29577062
3D Print Addit Manuf. 2016 Dec 01;3(4):226-235. doi: 10.1089/3dp.2016.0042.

Additive manufacturing by layerwise photopolymerization, commonly called stereolithography (SLA), is attractive due to its high resolution and diversity of materials chemistry. However, traditional SLA methods are restricted to planar substrates and planar layers that are perpendicular to a single-axis...

Cite
Stevens AG, Oliver CR, Kirchmeyer M, et al. Conformal Robotic Stereolithography. 3D Print Addit Manuf. 2016;3(4):226-235doi: 10.1089/3dp.2016.0042.
Stevens, A. G., Oliver, C. R., Kirchmeyer, M., Wu, J., Chin, L., Polsen, E. S., Archer, C., Boyle, C., Garber, J., & Hart, A. J. (2016). Conformal Robotic Stereolithography. 3D printing and additive manufacturing, 3(4), 226-235. https://doi.org/10.1089/3dp.2016.0042
Stevens, Adam G, et al. "Conformal Robotic Stereolithography." 3D printing and additive manufacturing vol. 3,4 (2016): 226-235. doi: https://doi.org/10.1089/3dp.2016.0042
Stevens AG, Oliver CR, Kirchmeyer M, Wu J, Chin L, Polsen ES, Archer C, Boyle C, Garber J, Hart AJ. Conformal Robotic Stereolithography. 3D Print Addit Manuf. 2016 Dec 01;3(4):226-235. doi: 10.1089/3dp.2016.0042. PMID: 29577062; PMCID: PMC5363219.
Copy Download .nbib Format: NLM
Enhancing Zeolite Performance by Catalyst Shaping in a Mesoscale Continuous-Flow Diels-Alder Process.

ChemSusChem

Seghers S, Lefevere J, Mullens S, De Vylder A, Thybaut JW, Stevens CV.
PMID: 29577662
ChemSusChem. 2018 May 25;11(10):1686-1693. doi: 10.1002/cssc.201800362. Epub 2018 Apr 26.

In contrast to most lab-scale batch procedures, a continuous-flow implementation requires a thorough consideration of the solid catalyst design. In a previous study, irregular zeolite pellets were applied in a miniaturized continuous-flow reactor for the Diels-Alder reaction in the...

Cite
Seghers S, Lefevere J, Mullens S, et al. Enhancing Zeolite Performance by Catalyst Shaping in a Mesoscale Continuous-Flow Diels-Alder Process. ChemSusChem. 2018;11(10):1686-1693doi: 10.1002/cssc.201800362.
Seghers, S., Lefevere, J., Mullens, S., De Vylder, A., Thybaut, J. W., & Stevens, C. V. (2018). Enhancing Zeolite Performance by Catalyst Shaping in a Mesoscale Continuous-Flow Diels-Alder Process. ChemSusChem, 11(10), 1686-1693. https://doi.org/10.1002/cssc.201800362
Seghers, Sofie, et al. "Enhancing Zeolite Performance by Catalyst Shaping in a Mesoscale Continuous-Flow Diels-Alder Process." ChemSusChem vol. 11,10 (2018): 1686-1693. doi: https://doi.org/10.1002/cssc.201800362
Seghers S, Lefevere J, Mullens S, De Vylder A, Thybaut JW, Stevens CV. Enhancing Zeolite Performance by Catalyst Shaping in a Mesoscale Continuous-Flow Diels-Alder Process. ChemSusChem. 2018 May 25;11(10):1686-1693. doi: 10.1002/cssc.201800362. Epub 2018 Apr 26. PMID: 29577662.
Copy Download .nbib Format: NLM
Specialty Payment Model Opportunities and Assessment: Oncology Model Design Report.

Rand health quarterly

Huckfeldt PJ, Chan C, Hirshman S, Kofner A, Liu JL, Mulcahy AW, Popescu I, Stevens C, Timbie JW, Hussey PS.
PMID: 28083364
Rand Health Q. 2015 Jul 15;5(1):11. eCollection 2015 Jul 15.

This article describes research related to the design of a payment model for specialty oncology services for possible testing by the Center for Medicare and Medicaid Innovation at the Centers for Medicare & Medicaid Services (CMS). Cancer is a...

Cite
Huckfeldt PJ, Chan C, Hirshman S, et al. Specialty Payment Model Opportunities and Assessment: Oncology Model Design Report. Rand Health Q. 2015;5(1):11
Huckfeldt, P. J., Chan, C., Hirshman, S., Kofner, A., Liu, J. L., Mulcahy, A. W., Popescu, I., Stevens, C., Timbie, J. W., & Hussey, P. S. (2015). Specialty Payment Model Opportunities and Assessment: Oncology Model Design Report. Rand health quarterly, 5(1), 11.
Huckfeldt, Peter J, et al. "Specialty Payment Model Opportunities and Assessment: Oncology Model Design Report." Rand health quarterly vol. 5,1 (2015): 11.
Huckfeldt PJ, Chan C, Hirshman S, Kofner A, Liu JL, Mulcahy AW, Popescu I, Stevens C, Timbie JW, Hussey PS. Specialty Payment Model Opportunities and Assessment: Oncology Model Design Report. Rand Health Q. 2015 Jul 15;5(1):11. eCollection 2015 Jul 15. PMID: 28083364; PMCID: PMC5158244.
Copy Download .nbib Format: NLM
Experimental production of testicular teratomas in the mouse.

International journal of andrology

Stevens LC.
PMID: 29112245
Int J Androl. 1981 Mar;4:54-59. doi: 10.1111/j.1365-2605.1981.tb00652.x.

Testicular teratomas are congenital tumours that are extremely rare in mice except for the inbred strain 129 and strains derived from it. A third of the males of strain 129/Sv-ter has spontaneous teratomas. Teratomas may be easily produced experimentally...

Cite
Stevens LC. Experimental production of testicular teratomas in the mouse. Int J Androl. 1981;4:54-59doi: 10.1111/j.1365-2605.1981.tb00652.x.
Stevens, L. C. (1981). Experimental production of testicular teratomas in the mouse. International journal of andrology, 454-59. https://doi.org/10.1111/j.1365-2605.1981.tb00652.x
Stevens, Leroy C. "Experimental production of testicular teratomas in the mouse." International journal of andrology vol. 4 (1981): 54-59. doi: https://doi.org/10.1111/j.1365-2605.1981.tb00652.x
Stevens LC. Experimental production of testicular teratomas in the mouse. Int J Androl. 1981 Mar;4:54-59. doi: 10.1111/j.1365-2605.1981.tb00652.x. PMID: 29112245.
Copy Download .nbib Format: NLM
Identification of natural products as novel ligands for the human 5-HT.

Biophysics reports

Peng Y, Zhao S, Wu Y, Cao H, Xu Y, Liu X, Shui W, Cheng J, Zhao S, Shen L, Ma J, Quinn RJ, Stevens RC, Zhong G, Liu ZJ.
PMID: 29577069
Biophys Rep. 2018;4(1):50-61. doi: 10.1007/s41048-018-0047-1. Epub 2018 Mar 09.

G protein-coupled receptors (GPCRs) constitute the largest human protein family with over 800 members, which are implicated in many important medical conditions. Serotonin receptors belong to the aminergic GPCR subfamily and play important roles in physiological and psychological activities....

Cite
Peng Y, Zhao S, Wu Y, et al. Identification of natural products as novel ligands for the human 5-HT. Biophys Rep. 2018;4(1):50-61doi: 10.1007/s41048-018-0047-1.
Peng, Y., Zhao, S., Wu, Y., Cao, H., Xu, Y., Liu, X., Shui, W., Cheng, J., Zhao, S., Shen, L., Ma, J., Quinn, R. J., Stevens, R. C., Zhong, G., & Liu, Z. J. (2018). Identification of natural products as novel ligands for the human 5-HT. Biophysics reports, 4(1), 50-61. https://doi.org/10.1007/s41048-018-0047-1
Peng, Yao, et al. "Identification of natural products as novel ligands for the human 5-HT." Biophysics reports vol. 4,1 (2018): 50-61. doi: https://doi.org/10.1007/s41048-018-0047-1
Peng Y, Zhao S, Wu Y, Cao H, Xu Y, Liu X, Shui W, Cheng J, Zhao S, Shen L, Ma J, Quinn RJ, Stevens RC, Zhong G, Liu ZJ. Identification of natural products as novel ligands for the human 5-HT. Biophys Rep. 2018;4(1):50-61. doi: 10.1007/s41048-018-0047-1. Epub 2018 Mar 09. PMID: 29577069; PMCID: PMC5860131.
Copy Download .nbib Format: NLM
Patents and literature.

Applied biochemistry and biotechnology

Kit M, Narasimhan MJ, Anderson JA, Zimmermann U, Pilwat G, Furuya T, Tani Y, Kolehmainen SE, Tarkkanen V, Barrett SP, Gestrelius SM, Belloc A, Florent J, Lunel J, Palla J, Mancy D, Bailey JE, Cho YK, Mouri T, Kayama H, Foley SE, Oriel PJ, Epstein CC, Kimura K, Spraker PW, Ljungdahl LG, Wieget JK, Levine DW, Thilly WG, Wang DI, Wong JS, Eisinger MG, Young FE, Wilson GA, Mottice SL, Green H, Kehinde O, Buhler M, Olofsson M, Osseux PF, Degen L, Branduzzi P, Olivieri R, Cimini N, Kang KS, Veeder GT, Latymer Z, Andersen G, Drobot W, Monsheimer R, Pfleiderer E, Hidaka H, Kohno T, Eida T, Weisrock WP, Stevens VC, Takezawa K, Hiratani H, Wandrey C, Wichmann R, Leuchtenberger W, Kula M, Buckmann A, Troller J, Koshugi J, Frommer W, Muller L, Schmidt D, Puls W, Krause H, Heber U, Cohen SN, Wahl GM, Stark GR, Collins J, Hohn B, Sugano H, Matsui Y.
PMID: 24234232
Appl Biochem Biotechnol. 1982 May;7(3):217-30. doi: 10.1007/BF02798299.

No abstract available.

Cite
Kit M, Narasimhan MJ, Anderson JA, et al. Patents and literature. Appl Biochem Biotechnol. 1982;7(3):217-30doi: 10.1007/BF02798299.
Kit, M., Narasimhan, M. J., Anderson, J. A., Zimmermann, U., Pilwat, G., Furuya, T., Tani, Y., Kolehmainen, S. E., Tarkkanen, V., Barrett, S. P., Gestrelius, S. M., Belloc, A., Florent, J., Lunel, J., Palla, J., Mancy, D., Bailey, J. E., Cho, Y. K., Mouri, T., Kayama, H., Foley, S. E., Oriel, P. J., Epstein, C. C., Kimura, K., Spraker, P. W., Ljungdahl, L. G., Wieget, J. K., Levine, D. W., Thilly, W. G., Wang, D. I., Wong, J. S., Eisinger, M. G., Young, F. E., Wilson, G. A., Mottice, S. L., Green, H., Kehinde, O., Buhler, M., Olofsson, M., Osseux, P. F., Degen, L., Branduzzi, P., Olivieri, R., Cimini, N., Kang, K. S., Veeder, G. T., Latymer, Z., Andersen, G., Drobot, W., Monsheimer, R., Pfleiderer, E., Hidaka, H., Kohno, T., Eida, T., Weisrock, W. P., Stevens, V. C., Takezawa, K., Hiratani, H., Wandrey, C., Wichmann, R., Leuchtenberger, W., Kula, M., Buckmann, A., Troller, J., Koshugi, J., Frommer, W., Muller, L., Schmidt, D., Puls, W., Krause, H., Heber, U., Cohen, S. N., Wahl, G. M., Stark, G. R., Collins, J., Hohn, B., Sugano, H., & Matsui, Y. (1982). Patents and literature. Applied biochemistry and biotechnology, 7(3), 217-30. https://doi.org/10.1007/BF02798299
Kit, M, et al. "Patents and literature." Applied biochemistry and biotechnology vol. 7,3 (1982): 217-30. doi: https://doi.org/10.1007/BF02798299
Kit M, Narasimhan MJ, Anderson JA, Zimmermann U, Pilwat G, Furuya T, Tani Y, Kolehmainen SE, Tarkkanen V, Barrett SP, Gestrelius SM, Belloc A, Florent J, Lunel J, Palla J, Mancy D, Bailey JE, Cho YK, Mouri T, Kayama H, Foley SE, Oriel PJ, Epstein CC, Kimura K, Spraker PW, Ljungdahl LG, Wieget JK, Levine DW, Thilly WG, Wang DI, Wong JS, Eisinger MG, Young FE, Wilson GA, Mottice SL, Green H, Kehinde O, Buhler M, Olofsson M, Osseux PF, Degen L, Branduzzi P, Olivieri R, Cimini N, Kang KS, Veeder GT, Latymer Z, Andersen G, Drobot W, Monsheimer R, Pfleiderer E, Hidaka H, Kohno T, Eida T, Weisrock WP, Stevens VC, Takezawa K, Hiratani H, Wandrey C, Wichmann R, Leuchtenberger W, Kula M, Buckmann A, Troller J, Koshugi J, Frommer W, Muller L, Schmidt D, Puls W, Krause H, Heber U, Cohen SN, Wahl GM, Stark GR, Collins J, Hohn B, Sugano H, Matsui Y. Patents and literature. Appl Biochem Biotechnol. 1982 May;7(3):217-30. doi: 10.1007/BF02798299. PMID: 24234232.
Copy Download .nbib Format: NLM
SU-E-J-187: Evaluation of the Effects of Dose on 4DCT-Calculated Lung Ventilation.

Medical physics

Latifi K, Dilling T, Hoffe S, Stevens C, Moros E, Zhang G.
PMID: 28519064
Med Phys. 2012 Jun;39(6):3695-3696. doi: 10.1118/1.4735028.

PURPOSE: To investigate the effects of radiation therapy (RT) treatment dose on ventilation.METHODS: Optical flow deformable image registration of the normal end-expiration and end-inspiration phases of 4DCT images was used to correlate the voxels between the two phases. 4DCT...

Cite
Latifi K, Dilling T, Hoffe S, et al. SU-E-J-187: Evaluation of the Effects of Dose on 4DCT-Calculated Lung Ventilation. Med Phys. 2012;39(6):3695-3696doi: 10.1118/1.4735028.
Latifi, K., Dilling, T., Hoffe, S., Stevens, C., Moros, E., & Zhang, G. (2012). SU-E-J-187: Evaluation of the Effects of Dose on 4DCT-Calculated Lung Ventilation. Medical physics, 39(6), 3695-3696. https://doi.org/10.1118/1.4735028
Latifi, K, et al. "SU-E-J-187: Evaluation of the Effects of Dose on 4DCT-Calculated Lung Ventilation." Medical physics vol. 39,6 (2012): 3695-3696. doi: https://doi.org/10.1118/1.4735028
Latifi K, Dilling T, Hoffe S, Stevens C, Moros E, Zhang G. SU-E-J-187: Evaluation of the Effects of Dose on 4DCT-Calculated Lung Ventilation. Med Phys. 2012 Jun;39(6):3695-3696. doi: 10.1118/1.4735028. PMID: 28519064.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 454 entries